Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is neededMark S. Butler, Peter Beyer, Laila Al-Sulaiman et al.|Archive ouverte UNIGE (University of Geneva)|2022Cited by 221
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Alexandra Meagan Cameron, Richard A. Alm et al.|Antimicrobial Agents and Chemotherapy|2024Cited by 25